首页> 中文期刊> 《中华实验外科杂志》 >微小RNA-202可通过转录后下调低密度脂蛋白受体相关蛋白6的表达抑制人肝癌细胞增殖

微小RNA-202可通过转录后下调低密度脂蛋白受体相关蛋白6的表达抑制人肝癌细胞增殖

摘要

目的 观察微小RNA(miRNA,miR)-202是否通过转录后下调癌基因低密度脂蛋白受体相关蛋白6(LRP6)的表达而抑制人肝癌细胞(HCC)的增殖.方法 培养HCC细胞株QGY-7703、HepG2;采用实时定量聚合酶链反应(Real-time PCR)检测细胞周期蛋白(Cyclin) D1、MYC和LEF1 mRNA的表达;Western blot检测LRP6、Cyclin D1、MYC、β-连环蛋白(β-catenin)和磷酸化Rb蛋白的表达;通过转染小干扰RNA (siRNA)抑制肝细胞癌(HCC)细胞LRP6的表达;构建pGL3-LRP6-3'端非编码区域(3'-UTR)-荧光素酶质粒转染HCC细胞作荧光素酶检测;采用噻唑蓝(MTT)法、克隆形成实验及贴壁不依赖性生长能力测定法检测HCC细胞的增殖能力.结果 在QGY-7703、HepG2两种细胞株均显示,过表达miR-202可以下调LRP6的表达,而抑制miR-202可以上调LRP6的表达(P<0.05);miR-202的过表达可以降低pGL3-LRP6-3'-UTR-荧光素酶报告基因中荧光素酶的活性,而抑制miR-202则可以增加其荧光素酶的活性(P<0.05);miR-202可以显著下调受Wnt/β-catenin调控的下游基因Cyclin D1、MYC和LEF1的表达,抑制miR-202则可以显著上调这些基因的表达(P<0.05);在miR-202过表达的HCC细胞,Cyclin D1、MYC、LEF1和磷酸化Rb蛋白的表达也显著下调,而抑制miR-202的表达,则可以上调这些蛋白的表达(P<0.05);miR-202的表达与LRP6蛋白的表达水平呈显著负相关(r =0.575,P<0.05);通过MTT法和克隆形成实验结果表明,沉默miR-202抑制组或阴性对照转染组细胞的LRP6,可以降低HCC细胞的生长速度和增殖(P<0.05);贴壁不依赖性生长能力测定也显示,LRP6抑制对miR-202抑制组HCC细胞的增殖具有显著抑制作用(P<0.05).结论 在HCC细胞,LRP6mRNA是miR-202的直接作用靶点;在miR-202发挥抑制HCC细胞增殖的作用中,LRP6抑制是必不可少的;LRP6可以作为HCC的潜在治疗靶点.%Objective To study whehter microRNA (miRNA,miR)-202 suppresses cell proliferation in human hepatocellular carcinoma (HCC) by downregulating low density lipoprotein receptor associated protein 6 (LRP6) post-transcriptionally.Methods The HCC cell lines QGY-7703 and HepG2 were cultured according to the manufacturer' s instruction.The relative expression levels of Cyclin D1,MYC and LEF1 mRNA were assessed by the real-time PCR analysis.The expression of c-Myc,Cyclin D1,β-catenin and phosphorylated Rb protein was assessed by Western blotting analysis.The small interfering RNA (siRNA) was used to inhibit the expression of LRP6 in HCC cells.The pGL3-LRP6-3' untranslated region (3'-UTR)-luciferase reporter was constructed and transfected into HCC cells to make luciferase assay.The methyl thiazol tetrazolium (MTT) assay,colony formation assay and anchorage-independent growth ability assay were used to assess the proliferation ability of HCC cells.Results The Western blotting analysis showed that LRP6 expression was downregulated by ectopic miR-202 and upregulated by miR-202 inhibitor in both QGY-7703 and HepG2 cells (P < 0.05).The luciferase reporter assay showed that ectopic expression of miR-202 decreased the luciferase activity of the pGL3-LRP6-3 '-UTR-luciferase reporter,and suppression of miR-202 increased luciferase production (P <0.05).The downstream genes regulated by Wnt/β-catenin (Cyclin D1,MYC and LEF1) were all significantly downregulated by miR-202,and upregulated by the miR-202 inhibitor (P < 0.05).Furthermore,the expression levels of c-Myc,Cyclin D1,β-catenin and phosphorylated Rb proteins were downregulated in miR-202 overexpressing cells,and upregulated in cells transfected with the miR-202 inhibitor (P < 0.05).There was an obviously negative correlation between the expression of miR-202 and the LRP6 protein levels (r =0.575,P < 0.05).Silencing LRP6 in miR-202 inhibitor or NC transfected cells decreased the growth rate and proliferation of cells,as assessed by MTT and colony formation assays (P < 0.05).The anchorage-independent growth ability of miR-202-inhibited cells was also significantly suppressed in response to LRP6 inhibition (P < O.05).Conclusion Our results suggested that LRP6 mRNA is a direct target of miR-202 in HCC cells.And the depletion of LRP6 is essential for miR-202-mediated inhibition of proliferation of HCC cells.

著录项

  • 来源
    《中华实验外科杂志》 |2015年第9期|2154-2156|共3页
  • 作者单位

    430071 武汉大学中南医院武汉大学肝胆疾病研究院武汉大学移植中心湖北省移植医学重点实验室;

    430071 武汉大学中南医院武汉大学肝胆疾病研究院武汉大学移植中心湖北省移植医学重点实验室;

    430071 武汉大学中南医院武汉大学肝胆疾病研究院武汉大学移植中心湖北省移植医学重点实验室;

    中南大学湘雅三医院卫生部移植医学工程技术中心;

    430071 武汉大学中南医院武汉大学肝胆疾病研究院武汉大学移植中心湖北省移植医学重点实验室;

    430071 武汉大学中南医院武汉大学肝胆疾病研究院武汉大学移植中心湖北省移植医学重点实验室;

  • 原文格式 PDF
  • 正文语种 chi
  • 中图分类
  • 关键词

    癌,肝细胞; 低密度脂蛋白受体相关蛋白6; 微小RNA-202; 增殖;

相似文献

  • 中文文献
  • 外文文献
  • 专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号